Vulnerability · CVE-2026-9489
NitroSense 3.x before 3.01.3052 contains Local Privilege Escalation (LPE) vulnerability.The program exposes a Windows Named Pipe that uses a custom protocol to invoke…
Published May 25, 2026 · catalog updated Jul 23, 2026 · the affected product
Check if you run it
No confirmed exploitation is on record for CVE-2026-9489. EPSS is 0.16%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High8.5
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.16%
- Remediation
- Not established
- Affected products
- See sources for product scope
NitroSense 3.x before 3.01.3052 contains Local Privilege Escalation (LPE) vulnerability.The program exposes a Windows Named Pipe that uses a custom protocol to invoke internal functions. However, this Named Pipe is misconfigured, allowing any authenticated local user to execute arbitrary code with NT AUTHORITY\SYSTEM privileges and to delete arbitrary files with SYSTEM privileges. By leveraging this, an attacker can execute arbitrary code on the target system with elevated privileges.
No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.
How to fix CVE-2026-9489
Recommended remediation
No required-action text, fix commit, or clear fixed-version range is stored yet.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-9489. EPSS is 0.16%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-22: Path Traversal; CWE-269: Improper Privilege Management; CWE-284: Improper Access Control. EPSS 0.16%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
May 25, 2026 · NIST NVD
Detected
NitroSense 3.x before 3.01.3052 contains Local Privilege Escalation (LPE) vulnerability.The program exposes a Windows Named Pipe that uses a custom protocol to invoke internal functions. However, this Named Pipe is misconfigured, allowing any authenticated local user to execute arbitrary code with NT AUTHORITY\SYSTEM privileges and to delete arbitrary files with SYSTEM privileges. By leveraging th
Jul 23, 2026 · NIST NVD
Updated
NitroSense 3.x before 3.01.3052 contains Local Privilege Escalation (LPE) vulnerability.The program exposes a Windows Named Pipe that uses a custom protocol to invoke internal functions. However, this Named Pipe is misconfigured, allowing any authenticated local user to execute arbitrary code with NT AUTHORITY\SYSTEM privileges and to delete arbitrary files with SYSTEM privileges. By leveraging th
Sources
- CVE.orgVulnerability recordCVE-2026-9489
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-9489
30-day exploitation probability 0.2%
first.org - NIST NVDVulnerability recordCVE-2026-9489
NitroSense 3.x before 3.01.3052 contains Local Privilege Escalation (LPE) vulnerability.The program exposes a Windows Named Pipe that uses a custom protocol to invoke internal functions. However, this Named Pipe is misconfigured, allowing any authenticated local user to execute a
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.